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ABSTRACT
While methylcytosines serve as the fifth base
encoding epigenetic information, they are also a
dangerous endogenous mutagen due to their intrin-
sic instability. Methylcytosine undergoes sponta-
neous deamination, at a rate much higher than
cytosine, to generate thymine. In mammals, two
repair enzymes, thymine DNA glycosylase (TDG)
and methyl-CpG binding domain 4 (MBD4), have
evolved to counteract the mutagenic effect of
methylcytosines. Both recognize G/T mismatches
arising from methylcytosine deamination and
initiate base-excision repair that corrects them to
G/C pairs. However, the mechanism by which
the methylation status of the repaired cytosines
is restored has remained unknown. We show
here that the DNA methyltransferase Dnmt3a
interacts with TDG. Both the PWWP domain and
the catalytic domain of Dnmt3a are able to mediate
the interaction with TDG at its N-terminus. The
interaction affects the enzymatic activity of both
proteins: Dnmt3a positively regulates the glycosy-
lase activity of TDG, while TDG inhibits the
methylation activity of Dnmt3a in vitro. These data
suggest a mechanistic link between DNA repair and
remethylation at sites affected by methylcytosine
deamination.
INTRODUCTION
DNA cytosine methylation is a common and rapidly evolving
epigenetic mechanism among higher eukaryotic organisms
with more complex genomes (1). In mammalian genomes,
5% of the cytosines are methylated. Methylcytosines occur
predominantly at CpG dinucleotides. DNA methylation is
essential for normal development due to its important roles
in genomic imprinting, X chromosome inactivation, silencing
of parasitic elements, regulation of tissue-speciﬁc gene
expression and the maintenance of heterochromatin (2,3).
The distribution of methylated and unmethylated CpGs in
genomic DNA is not random, but displays speciﬁc patterns
in any given type of cell (4,5). The generation of genomic
methylation patterns is a dynamic process that requires
demethylation and de novo methylation by the action of the
two de novo methyltransferases, Dnmt3a and Dnmt3b, during
gametogenesis and early embryonic development (6). Once
the methylation patterns are created, they are perpetuated
by the maintenance methyltransferase Dnmt1, leading to
somatic inheritance (2). Aberrant methylation is known to
contribute to tumorigenesis and other diseases (7–9).
However, methylcytosines are also a source of genomic
instability because they are prone to hydrolytic deamination
under physiological conditions. The deamination product of
a methylcytosine is thymine, a naturally occurring base. If
the mispaired thymine is not repaired, a C to T transition
will be ﬁxed following DNA replication. Since methylcy-
tosines exist in large numbers throughout the mammalian
genome (3 · 10
7 per haploid genome), they present a signiﬁ-
cant risk for mutagenesis. The mutation rate from methylcy-
tosine to thymine is 10- to 50-fold higher than for other types
of transitions (10,11). One-third of all germ-line point muta-
tions found in human diseases and an equal proportion of
somatic mutations associated with cancer occur at CpG
sites (12,13). The methylated CpG sites in the tumor suppres-
sor gene p53 are, for example, hot spots for mutation in
carcinogenesis (14,15).
In mammals, a speciﬁc base-excision repair pathway is
devoted to the correction of G/T mismatches arising due to
methylcytosine deamination (16,17). The repair process is
initiated by a DNA glycosylase, either thymine DNA glyco-
sylase (TDG) or methyl-CpG binding domain 4 (MBD4), that
recognizes and excises the mispaired thymine from the ribose
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site, a single nucleotide gap is then created by apurinic/
apyrimidinic endonuclease (APE, also known as HAP1,
APEX and Ref-1) that cleaves the phosphodiester bond
50 of the baseless deoxyribose. The APE–DNA complex is
then channeled into an appropriate base-excision repair
(BER) pathway (21). The repair is completed by the con-
certed action of DNA polymerase b (POLB), XRCC1 and
DNA ligase III (LIG3), which results in the replacement of
the missing nucleotide and the establishment of the continuity
of the DNA strand (16). The question then arises as to how
the original methylation state is restored to the cytosine left
by base-excision repair. It was reported that cytosine incorpo-
rated by DNA repair is remethylated in a replication-
independent manner (22), but the molecular mechanism
remains to be elucidated. In this study we demonstrate that
Dnmt3a interacts with TDG both in vitro and in vivo. Func-
tional assays with recombinant proteins indicate that Dnmt3a
stimulates the TDG glycosylase activity whereas in turn TDG
inhibits the methylation activity of Dnmt3a. The physical and
functional interaction with TDG suggests that Dnmt3a might
be the enzyme that remethylates the newly synthesized
cytosine to ensure stable maintenance of methylation after
base-excision repair.
MATERIALS AND METHODS
Plasmid constructs
Mouse TDG was cloned into the expression vector pFLAG-
CMV-2 (Sigma) and pCMV-Tag3C (Stratagene) to generate
Flag- and myc-tagged proteins, respectively. Full-length
human APE, POLB, XRCC1 and LIG3 were cloned into a
modiﬁed pCDNA4 vector in-frame with the Flag tag at the
N-terminus. The full-length coding region and various subre-
gions of TDG were cloned into pET28a (Novagen) and
pGADT7 (Clontech) for in vitro expression and yeast two-
hybrid assay. We veriﬁed all PCR-cloned constructs by
DNA sequencing.
Cell culture and transfections
Human embryonic kidney HEK 293T, 293 c18 (ATCC no.
CRL-10852) and mouse ﬁbroblast NIH 3T3 cells were
maintained in DMEM with standard supplements. Plasmid
constructs and G/T mismatch-containing DNA oligodup-
lexes were transfected into the cells using LipofectAMINE
(Invitrogen).
Reagents and antibodies
M.HhaI and M.SssI methyltransferases were from NEB.
Uracil DNA glycosylase (UDG) and micrococcal nuclease
were from Fermentas. The antibody speciﬁc for Dnmt3a
was raised and afﬁnity-puriﬁed as described previously
(23). The monoclonal anti-myc and polyclonal anti-HA
were from Santa Cruz, monoclonal anti-Flag and anti-HA
were from Sigma–Aldrich. The Alexa Fluor  546 goat anti-
rabbit IgG and Alexa Fluor  488 goat anti-mouse IgG were
purchased from Molecular Probes. The goat anti-mouse IgG
conjugated with indodicarbocyanine (Cy5) was from Jackson
ImmunoResearch.
Yeast two-hybrid assay
Two-hybrid screening was performed by mating a yeast strain
construct (AH109) harboring GAL4DB-Dnmt3a with a strain
(Y187) carrying a mouse testis expression library (Clontech).
Colonies were selected on the SD medium lacking His, Leu,
Trp and adenine according to the recommended protocol
(Clontech). The prey plasmids from positive clones were
isolated and transformed into Escherichia coli for identiﬁca-
tion. For mapping the region of Dnmt3a and TDG involved in
the interaction, Dnmt3a fragments were cloned in-frame with
GAL4 DNA binding domain (GAL4DB) on the bait vector
pGBKT7 (Clontech) and TDG fragments were fused with
the GAL4 activation domain (GAL4AD) on the prey vector
pGADT7.
Glutathione S-transferase (GST) pull-down assay
To conﬁrm the interaction of Dnmt3a and TDG, GST
pull-down assay was performed essentially as described
(24). A total of 2 mg of the GST–TDG fusion protein puriﬁed
from bacteria were incubated with glutathione Sepharose 4B
beads (Amersham Biosciences) in the binding buffer [20 mM
Tris–HCl (pH 7.9), 0.1 M NaCl, 1 mM EDTA, 5 mM MgCl2,
0.1% NP-40, 1 mM DTT, 0.2 mM phenylmethlysulfonyl ﬂuo-
ride (PMSF) and 20% glycerol] in a total volume of 200 mla t
4 C for 2 h. The GST–TDG slurry was washed with the bind-
ing buffer containing 1 M NaCl twice and equilibrated with
the binding buffer without EDTA twice. After the puriﬁed
Dnmt3a protein and the GST–TDG slurry were both treated
with micrococcal nuclease at a ﬁnal concentration of 0.1 U/
mla t3 0  C for 10 min, 500 ng of the Dnmt3a was added to
the slurry and incubated at 4 C for another 2 h. The Sephar-
ose beads were vigorously washed ﬁve times with the binding
buffer, and bound proteins were fractionated by SDS–PAGE
and visualized by immunoblotting.
For mapping the interaction domain of TDG or Dnmt3a,
2 mg of the puriﬁed GST–Dnmt3a or GST–TDG fusion pro-
tein were incubated with glutathione Sepharose 4B beads
(Amersham Biosciences) in the binding buffer [20 mM
Tris–HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM
DTT, 1 mg/ml leupeptin and 1 mM PMSF] in a total volume
of 500 mla t4  C for 2 h. A total of 15 mlo f
35S-labeled TDG
or Dnmt3a polypeptides synthesized with the in vitro
transcription/translation system (Promega) were then added
to the slurry and incubated at 4 C for another 2 h. The
Sepharose beads were vigorously washed ﬁve times with
the binding buffer containing 0.1% Triton X-100, and
bound proteins were fractionated by SDS–PAGE and visual-
ized by autoradiography. In vitro translated APE, POLB,
XRCC1 and LIG3 were also incubated with GST–Dnmt3a
to detect the interaction using the same protocol.
Immunoprecipitation
For the co-immunoprecipitation assay, 5 · 10
6 of transfected
293T cells were lysed in lysis buffer [50 mM Tris–HCl (pH
7.5), 1 mM EDTA, 150 mM NaCl, 0.8% NP-40, 10% glyc-
erol, 0.5 mg/ml BSA, 1 mg/ml pepstain A, 1 mg/ml leupeptin,
1.7 mg/ml aprotinin and 1 mM PMSF]. Supernatants were
incubated with the IP antibody at 4 C for 2 h. Protein A-
Sepharose beads (Amersham Biosciences) were added and
the mixture was rotated at 4 C for 3 h. Immunoprecipitates
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Proteins in the immunoprecipitates were analyzed by stan-
dard western blotting.
Immunofluorescence
Indirect immunoﬂuorescence staining to study the co-
localization of transfected Dnmt3a and TDG in 3T3 cells
was carried out as described (23) and images of stained
cells were captured with a Nikon ﬂuorescence microscope
(E600) and a confocal laser scanning microscope (Leica).
The G/T mismatch-containing DNA oligoduplexes used for
transfection were prepared by annealing the T-strand oligonu-
cleotide (50-FAM-AGCTGCGCGCAATTGATCGCCGGAC-
GT-30, 27mer) labeled with FAM (ﬂuorescein) at the 50 end
with an equal molar amount of the G strand oligonucleotide
(50-ACGTCCGGCGATCGATTGCGCGCAGCT-30, 27mer).
The matched FAM-labeled oligoduplexes were prepared by
annealing FAM-labeled C-strand oligonucleotide (50-FAM-
AGCTGCGCGCAATCGATCGCCGGACGT-30, 27mer) with
the G strand oligonucleotide. The 26th nucleotide of each
strand was modiﬁed by phosphorothiate to prevent exonucle-
olytic degradation within the transfected cells.
Protein expression and purification
The coding sequences of TDG, Dnmt3a were cloned into
pGEX4T-3 (Pharmacia) for expression of the GST-fusions
in the E.coli strain BL21 (DE3). Protein puriﬁcation from
cells induced with 0.5 mM isopropyl-b-D-thiogalactopyra-
noside (IPTG) at 27 C for 3 h was performed using
glutathione Sepharose 4B (Amersham Biosciences) according
to the manufacturer’s instruction. For GST–TDG, the eluate
was dialyzed and loaded again onto a Mono S HR 5/5 cation
exchange column (Amersham Biosciences) equilibrated with
buffer A [25 mM sodium phosphate (pH 7.0), 0.1 M NaCl,
1 mM EDTA, 10% glycerol, 0.01% Triton X-100, 1 mM
DTT and 0.25 mM PMSF]. Bound proteins were eluted
with a linear gradient of 0.1–0.8 M NaCl in buffer A.
GST–TDG appeared in fractions eluted around 0.5 M NaCl.
Puriﬁed GST fusion proteins were dialyzed against 20 mM
Tris–HCl (pH 7.5), 100 mM NaCl, 1 mM EDTA, 1 mM
DTT and 15% glycerol prior to use or storage in aliquots.
For expression and puriﬁcation of 6xHis-tagged Dnmt3a
and TDG, the respective coding sequences were cloned into
pET28a (Novagen). His-Dnmt3a was expressed and puriﬁed
from E.coli strain BL21 (DE3) as described (25). 6xHis-
TDG was induced at a cell density of 0.7 A600 nm for 2.5 h
at 37 C with 1 mM IPTG and puriﬁed with Nickel NTA agar-
ose (Qiagen), followed by chromatography on a Mono S HR
5/5 column using the conditions described above. 6xHis-TDG
appeared in fractions eluted around 0.33 M NaCl. Puriﬁed
enzymes were dialyzed against 20 mM HEPES (pH 7.5),
1 mM EDTA, 1 mM DTT and 15% glycerol prior to use or
storage in aliquots.
6xHis-TDG was also puriﬁed in two chromatographic
steps. After lysis of the cells and removal of cell debris by
centrifugation at 20000 g for 30 min, the soluble protein frac-
tion was loaded onto a 1 ml Hi-Trap Heparin column (Amer-
sham Pharmacia Biotech) equilibrated with Buffer A [25 mM
sodium phosphate (pH 7.0), 1 mM EDTA, 10% glycerol,
1 mM DTT and 0.25 mM PMSF]. Bound proteins were eluted
with a linear gradient of 0.1–0.8 M NaCl in buffer A. The
glycosylase eluted at the beginning of the 600 mM NaCl
step. The thymine DNA glycosylase preparation was further
puriﬁed on a Mono S HR 5/5 column (Amersham Pharmacia
Biotech). 6xHis-TDG was loaded in Buffer A containing
100 mM NaCl and then eluted at around 0.33 M NaCl.
6xHis-Dnmt3L, 6xHis-Dnmt2 and 6xHis-APE were
expressed in E.coli BL21 (DE3) and puriﬁed similarly with
Nickel NTA agarose (Qiagen) according to the manufac-
turer’s instruction. Recombinant heterochromatin protein
HP1 and human glycosylase SMUG1 were puriﬁed as GST-
fusions according to the recommended protocol (Amersham
Biosciences). For SMUG1, the GST tag was removed with
Factor Xa protease cleavage.
Glycosylase activity assay
The glycosylase activity of TDG was analyzed with the ‘nick-
ing’ procedure described previously (26) with modiﬁcations in
substrate sequenceand reactionbufferconditions. Thesubstrate
DNA containing a single G/T mismatch was prepared by
annealing the T-strand oligonucleotide (50-AGCTGCGCGC-
AATTGATCGCCGGACGT-30) labeled by [g-
32P]ATP at
the 50 end with an equal molar amount of the G strand
oligonucleotide (50-ACGTCCGGCGATCGATTGCGCGCA-
GCT-30). The nicking reaction by TDG was carried out at
30 C with 10 nM of the substrate DNA in 25 mM HEPES
(pH 7.8), 0.5 mM EDTA, 0.5 mM DTT, 0.5 mg/ml BSA as
described by Neddermann et al.( 1 8 )o r2 5m MH E P E S
(pH 7.8), 50 mM NaCl, 2 mM MgCl2, 0.5 mM EDTA,
0.5 mM DTT, 0.5 mg/ml BSA as described by Shimizu
et al. (27). 6xHis-Dnmt3a, 6xHis-APE, 6xHis-Dnmt2, M.SssI
and M.HhaI were added to test their effects, if any, on the TDG
activity. Where appropriate, Dnmt3a storage buffer was added
to normalize the reaction conditions. To convert the AP sites in
the DNA duplex into single-strand breaks, NaOH and EDTA
were added to a ﬁnal concentration of 90 and 10 mM, respec-
tively, and the reaction was heated at 100 Cf o r5m i n .T h e
samples were then resolved on a 20% denaturing polyacry-
lamide gel followed by autoradiography. Radioactivity of the
cleavage product band and the uncleaved substrate band was
quantiﬁed using the Storm instrument and ImageQuant soft-
ware (Molecular Dynamics).
The G/U glycosylase activity of TDG, UDG and SMUG1
was measured with the same assay except that a G/U
mismatch was incorporated in the place of G/T in the DNA
substrate.
In vitro DNA methylation activity assay
DNA methylation activity was determined as described (28).
A biotinylated 2.5 kb PCR fragment ampliﬁed from the
EBNA1 region of p220.2 (29) was used as substrate. The
sequence of the PCR primers were 50-biotin-TCATGCCATC-
CGTAAGATGC-30 and 50-CTGGTTGCTCCCATTCTTAG-
30. The methylation reaction mix contained 33 nM Dnmt3a,
a given amount of TDG or Dnmt3L (33 nM) or HP1
(33 nM), 4 mg/ml of DNA, and 5.3 mM S-[methyl-
3H] Ado-
Met (15 Ci/mmol; Amersham Biosciences) in a total volume
of 25 ml with a reaction buffer comprising 20 mM HEPES
(pH 7.5), 1 mM EDTA and 0.2 mM DTT. The reaction
was incubated at 37 C for up to 60 min before scintillation
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and M.HhaI were measured using the same method.
In vivo DNA methylation assay
In vivo methylation activity of Dnmt3a was assessed as
described (29). A total of 0.5 mg of the episomal assay
plasmid p220.2 were co-transfected into 293 c18 cells in
35 mm dishes in combination with Dnmt3a and TDG con-
structs. Cells were replated into 100 mm dishes after 2
days. An aliquot of cells was used to conﬁrm the expression
of the transfected proteins by western analysis. The p220.2
plasmid was recovered from the transfected cells and digested
with HhaI. The digestion pattern was analyzed by Southern
hybridization using a
32P-labeled probe derived from the
EBNA1 region of p220.2.
Avidin-biotin coupled DNA binding (ABCD) assay
The DNA binding capacity of TDG and Dnmt3a in vitro was
assessed as described previously (30). Approximately
10 pmol of biotin labeled G/T or G/C oligoduplexes (the
sequence is the same as used in the immunoﬂuorescence
assay) were incubated with 300 ng of puriﬁed recombinant
proteins in the presence of 50 pmol unlabeled G/C oligodu-
plexes at 4 C for 1 h in ABCD buffer [50 mM Tris–HCl
(pH 7.9), 150 mM NaCl, 10% glycerol, 5 mM MgCl2,
0.1% NP-40, 0.1% CHAPS and 0.5 mM DTT], then 10 ml
streptavidin-coated Sepharose beads (Amersham Bio-
sciences) were added and the mixture was rotated at 4 C
for 30 min. Precipitates were collected and washed four
times with the ABCD buffer. Proteins in the precipitates
were analyzed by standard western blotting.
RESULTS
TDG interacts directly with Dnmt3a
In an attempt to identify regulatory factors for DNA methy-
lation, we searched for interaction partners of Dnmt3a by
using yeast two-hybrid screening. From a mouse testis library
of 7 · 10
6 transformants, ﬁve positive clones were isolated
and characterized as encoding TDG.
The interaction between Dnmt3a and TDG was veriﬁed by
a GST pull-down assay. Recombinant 6xHis-Dnmt3a and
GST–TDG puriﬁed from E.coli were used. As shown in
Figure 1A, a signiﬁcant amount of Dnmt3a ( 6% of the
input) was co-precipitated with GST–TDG (Figure 1A,
lane 3) but not with GST alone (lane 2). This result shows
a direct interaction of the two proteins in vitro. The possibil-
ity of false positive interaction mediated by contaminating
nucleic acids was eliminated by including micrococcal nucle-
ase treatment in the GST pull-down assay: results were ident-
ical with or without this step, and a control for the digestion is
also shown (Figure 1A, right panel).
To examine the interaction between Dnmt3a and TDG
in vivo, we prepared mammalian expression constructs encod-
ing epitope-tagged proteins for a co-immunoprecipitation
assay. Whole extracts from 293T cells transfected with HA-
Dnmt3a and Flag-TDG were immunoprecipitated with
an anti-Flag antibody. Western analysis revealed that
HA-Dnmt3a was immunoprecipitated in the presence of
Flag-TDG (Figure 1B, lane 4). The co-immunoprecipitation
was speciﬁc because no signal was detected from the cell
extract without Flag-TDG (lane 2). These data indicate that
the two proteins can form a complex in transfected cells.
We then examined the distribution of co-transfected HA-
Dnmt3a and myc-TDG in 3T3 cells. As expected, Dnmt3a
displayed a diffuse nuclear pattern with discrete intense
spots largely overlapping with heterochromatin domains
deﬁned by bright DAPI staining in >80% of cells, whereas
only diffuse nuclear staining was observed with myc-TDG
(Figure 1C). We consistently observed that co-expression
of HA-Dnmt3a and myc-TDG resulted in a change of the
Figure 1. Dnmt3a interacts with TDG in vitro and in vivo.( A) Direct
interaction of Dnmt3a with TDG. Western analysis of the recombinant
Dnmt3a in fractions obtained from a GST pull-down assay using GST (lane 2)
or GST–TDG (lane 3). 10% of the input Dnmt3a was loaded (lane 1). IB:
antibody used for immunoblotting. Removal of any contaminating DNA from
the protein samples prior to the pull-down experiment was verified by
examining a sample spiked with l DNA (100 ng/ml) on an agarose gel after
the micrococcal nuclease digestion step (right panel). (B) Co-
immunoprecipitation of transfected Dnmt3a with TDG from 293T cells.
Western analysis of HA-Dnmt3a in whole cell extract (In) (lanes 1 and 3 with
10% of the input loaded) and immunoprecipitates (IP) obtained with anti-Flag
antibody from extracts of cells transfected with HA-Dnmt3a and empty Flag
vector (lane 2) or Flag-TDG expression construct (lane 4). (C) Nuclear co-
localization of transfected HA-Dnmt3a (red) and myc-TDG (green) in NIH
3T3 cells. Fluorescence immunostaining of cells expressing either myc-TDG,
HA-Dnmt3a or both was performed using the antibodies indicated on top.
Merge of the double stained images allows assessment of the degree of co-
localization of nuclear foci. DAPI counter-staining defines the nuclear
territory including heterochromatin domains.
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in the heterochromatin domains where HA-Dnmt3a was
located in the majority of co-transfected cells (over 60%).
To further investigate whether Dnmt3a can be targeted to a
G/T mismatched site, a ﬂuorescently-labeled DNA duplex
containing a single G/T mismatch was transfected into 3T3
cells together with myc-TDG and HA-Dnmt3a. Signal
from the G/T mismatch-containing oligoduplexes appeared
strongly in the nucleus and weakly in the cytoplasm
(Figure 2A), consistent with previous observations with trans-
fected DNA (31). Dnmt3a was mainly located in the nucleus
when co-transfected with the mismatched oligo. However, it
became distributed throughout the whole cell (in over 80% of
cells) when co-transfected with both the G/T mismatch oligo
and TDG (4th row). In contrast, both TDG and Dnmt3a
remained nuclear when a control matched oligo was used
(last row). Therefore, Dnmt3a is recruited to the cytoplasm
in the presence of TDG and G/T mismatch-containing
oligoduplexes. Although repair does not occur in the cyto-
plasm in normal cells, these data nevertheless indicate that
Dnmt3a can be recruited to G/T mismatch sites through its
association with TDG. The avidin–biotin coupled DNA bind-
ing assay (Figure 2B) further suggests a sequential binding of
TDG and Dnmt3a onto G/T oligoduplexes.
Interaction domains of Dnmt3a and TDG
Dnmt3a has a catalytic domain at the C-terminus, fused to a
long regulatory region including a conserved PWWP domain,
a PHD domain and an N-terminal part of  250 amino acids
Figure 2. (A) TDG recruits Dnmt3a to oligos containing G/T mismatches in vivo. Co-localization of the transfected FAM-labeled G/T mismatch-containing
DNA oligoduplexes (green), HA-Dnmt3a (red) and myc-TDG (pseudo-colored blue) in NIH 3T3 cells is shown. 300 pmol of DNA oligoduplexes were
transfected into 3T3 cells grown in a 35 mm-dish either alone or with HA-Dnmt3a (1 mg), myc-TDG (1 mg), or a combination. Fluorescence imaging of
transfected cells was performed by immunostaining using antibodies and FAM detection as indicated on the top. Merge of the images from the three left columns
allows assessment of the degree of co-localization. DAPI counter-staining (pseudo-colored white) defines the nuclear territory including heterochromatin
domains. Results shown are representative of three independent experiments. (B) Purified recombinant Dnmt3a binds to G/T mismatch-containing DNA
oligoduplexes via the association with recombinant TDG. An avidin–biotin coupled DNA binding (ABCD) assay (see Materials and Methods) was performed
with biotinylated G/T or G/C oligoduplexes and recombinant Dnmt3a alone or with TDG. The precipitates pulled down by the oligoduplexes were analyzed by
western blotting.
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PWWP domain is responsible for targeting the enzyme to
heterochromatin in the nucleus (23,33) and the PHD domain
mediates interaction with histone deacetylase (34).
To map the TDG-interacting domain of Dnmt3a, a deletion
analysis was performed using a yeast two-hybrid assay. Frag-
ments of Dnmt3a were expressed as fusion proteins with
GAL4DB domain and tested for interaction with TDG
fused with the GAL4 activation domain. Yeast expressing
either the PWWP (270–430 amino acid) or catalytic domains
(592–908 amino acid) could grow on the selective medium
lacking His, Leu, Trp and adenine (Figure 3A), but neither
the N-terminal part nor PHD domain endowed growth poten-
tial. Therefore, Dnmt3a appears to encompass two separate
regions, the PWWP domain and the catalytic domain, either
of which alone is sufﬁcient for mediating the interaction with
TDG. The TDG-interacting capacity of the two regions was
conﬁrmed by GST pull-down assay (Figure 3B).
TDG is a monofunctional glycosylase with the conserved
catalytic domain spanning the major length of the protein
(Figure 3C). While a region from 99 to 347 amino
acid encodes the G/U glycosylase activity, an additional
N-terminal sequence of 43–98 amino acid is required to
process G/T mismatches (18,35). To map the interaction
domain in TDG, GST pull-down assays were performed
using the recombinant GST–Dnmt3a fusion protein and
35S-
labeled TDG fragments synthesized in vitro. As shown in
Figure 3C, all ﬁve fragments from the N-terminal half of
TDG were able to bind to Dnmt3a, while the C-terminal
region (198–397 amino acid) failed to do so. The N-terminal
half contains at least two subdomains (1–52 and 121–205
amino acid), both of which can mediate interaction with
Dnmt3a individually. Yeast two-hybrid assay conﬁrmed
the Dnmt3a-interacting capacity of the regions from the
N-terminal half of TDG (Figure 3D).
Dnmt3a stimulates the glycosylase activity of TDG
Since the interaction of Dnmt3a and TDG involves their
respective catalytic domains, we wanted to know whether
they could functionally modulate each other’s enzymatic
activity. To this end, the glycosylase activity of TDG was
measured in the presence and absence of puriﬁed Dnmt3a.
We ﬁrst expressed and puriﬁed recombinant His-tagged
Dnmt3a and TDG from E.coli, and prepared a
32P-labeled
oligonucleotide duplex containing a G/T mismatch as sub-
strate (Figure 4A). APE, an endonuclease known to stimulate
the TDG activity, was also puriﬁed and used for comparison.
Figure 3. Mapping of Dnmt3a-TDG interaction domains. (A) Schematic representation of Dnmt3a fragments with their TDG-interacting abilities (shown on the
right) based on the data from yeast two-hybrid assays (lower panel). Coordinates of the first and last amino acids of each Dnmt3a construct are given at the left.
Yeast strain AH109 was co-transformed with a full-length TDG prey construct (GAL4AD fusion) and a bait construct (GAL4DB fusion) containing a Dnmt3a
fragment from different regions. Growth of colonies on the SD minimal media lacking leucine, trypsine, adenine and histidine (SD-L-T-A-H) reflects positive
interaction of a Dnmt3a fragment with TDG. (B) The binding abilities of in vitro translated,
35S-labeled Dnmt3a fragments assessed by GST pull-down assay. I,
10% of input Dnmt3a fragments; C, bound fractions from the GST control; B, bound fractions from the GST–TDG fusion. (C) Schematic representation of TDG
fragments with their Dnmt3a-interacting abilities (shown on the right) based on the data from GST pull-down assays (lower panel). The binding abilityo fin vitro
translated,
35S-labeled TDG fragment was tested with a GST–Dnmt3a fusion. I, 10% of input TDG fragments; C, bound fractions from the GST control; B, bound
fractions from the GST–Dnmt3a fusion. (D) Confirmation of the N-terminal interacting regions of TDG using yeast two-hybrid assay. Yeast strain AH109
containing the full-length Dnmt3a bait construct and three N-terminal fragments of TDG prey constructs could grow on the SD minimal media (SD-L-T-A-H).
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excision of mismatched thymine by TDG leaves an abasic
site where the DNA strand breaks under hot alkaline treatment.
As shown in Figure 4B, the amount of a 13mer break-down
product increased when Dnmt3a was included in the reaction.
Addition of 20 nM Dnmt3a resulted in a stimulation of TDG
activity by 2.5-fold on average (Figure 4B, compare lanes 3
and 2), and 100 nM Dnmt3a brought about a stimulation of
3.8-fold (Figure 4B, compare lanes 4 and 2) under standard
conditions reported previously (18). Moreover, the stimulatory
effect appeared to be slightly stronger than that of APE
(lanes 6 and 7). The fold stimulation by APE was consistent
with previously reported data (21,27). We have also observed
that puriﬁed Dnmt3a alone showed no detectable glycosylase
activity, ruling out the possibility of contamination with
a potent bacterial glycosylase in the Dnmt3a preparation
(Figure 4B, lane 5). The reactions containing less than
100 nM Dnmt3a were made up to a similar volume with pro-
tein storage buffer, ensuring that the stimulatory effects were
not due to alteration of salt or glycerol concentration. In addi-
tion, a similar degree of stimulation by Dnmt3a was also
observed using a different reaction buffer containing 50 mM
NaCl (27) (Figure 4B, lanes 11 and 12), ruling out any effects
which might be due to salt in the preps.
Figure 4. Dnmt3a stimulates the glycosylase activity of TDG. (A) Purified recombinant 6xHis-tagged Dnmt3a, APE and TDG proteins (Coomassie blue
staining). The purity of Dnmt3a, APE and TDG was about 85, 90 and 80%, respectively, as determined by densitometry. Lower panel, the G/T mismatch-
containing substrate (27 bp) used for the glycosylase activity assay. The upper T-containing strand was labeled with
32P at the 50 end. (B) Glycosylase activity
assay for TDG in the absence and presence of Dnmt3a or APE. The reactions in lanes 1–9 contained 25 mM HEPES (pH 7.8), 0.5 mM EDTA, 0.5 mM DTT,
0.5mg/ml BSA and 10 nM substrate DNA. The reactions in lanes 10–12 contained 50 mM NaCl and 2 mM MgCl2 in addition to the above and show no
difference, ruling out any possibility that the stimulation is only due to the addition of salt from the Dnmt3a prep. All reactions were incubated at 30 C for 1 h.
The excision of unpaired thymine resulted in breakage of the upper strand upon subsequent hot alkaline treatment. The generation of the 13mer breakage product
was examined by separation on a denaturing gel followed by quantification with phosphoimaging. The lower panel is a bar graph representation of TDG
enzymatic assays. The activity of TDG alone was set to 1. The relative activity (given on the y-axis) for each reaction is the average of three experiments ±SD.
(C) The kinetics of the base-excision reaction of TDG with and without Dnmt3a. DNA substrate (10 nM) was incubated with TDG (4 nM) alone or with Dnmt3a
(20 nM) in the reaction buffer without NaCl for different time periods indicated on the top. The lower panel is a line graph representation in which the activity for
each reaction at different time points is the average of three experiments ±SD. (D) Specific stimulation of TDG glycosylase activity by Dnmt3a. The glycosylase
reaction was carried out for 30 min at 30 C. The upper panel shows the lack of stimulation of two other glycosylases UDG and SMUG1 by Dnmt3a. The DNA
substrate used here had the same sequence as shown in (A) except that a G/U mismatch was incorporated in the place of G/T. The lower panel shows the absence
of stimulation by M.SssI, M.HhaI and Dnmt2 on the glycosylase activity of TDG.
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60 min of incubation, we next asked whether the stimulation
of TDG by Dnmt3a could also occur in the initial phase of the
reaction. Consistent with previous work (27), a fast initial
reaction was seen in the ﬁrst 5 min in the absence of
Dnmt3a (Figure 4C). With the addition of 20 nM Dnmt3a,
the reaction was accelerated by 2- to 4-fold as calculated
from the measurements at the time points of 0.5, 1, 2 and
5 min. This observation suggests that the interaction with
Dnmt3a may facilitate the binding of the TDG enzyme
with the mismatch substrate and/or excision of the thymine.
To further examine whether the stimulation by Dnmt3a is
speciﬁc for TDG, we tested its effect on other glycosylases,
the E.coli uracil DNA glycosylase (UDG) and its human
homologue SMUG1. The glycosylase activity assay was con-
ducted using the same DNA fragment (Figure 4A) but con-
taining a G/U mismatch instead of G/T. We found that
Dnmt3a had no effect on the activity of UDG and SMUG1
(Figure 4D, upper panel, lanes 2–5), while it stimulated the
G/U activity of TDG (Figure 4D, upper panel, lanes 6 and 7).
Moreover, the mouse DNA methyltransferase homologue
Dnmt2 and bacterial methyltransferases M.SssI and M.HhaI
did not stimulate the TDG activity (Figure 4D, lower
panel). Taken together, these results indicate that Dnmt3a
speciﬁcally stimulates the catalytic activity of TDG.
It should be noted that the speciﬁc activity (0.05–0.3 mol/
h/mol enzyme) of our TDG enzyme preparation was similar
to that reported by several other labs (18,27,30) but about
3- to 15-fold lower than that reported by Waters et al. (21).
It is likely that a signiﬁcant fraction of TDG molecules
were inactive, potentially due to protein misfolding. There-
fore, we could not formally exclude the possibility that
Dnmt3a may also stimulate TDG activity through promoting
conversion of its inactive form into the active form. Never-
theless, the stimulatory effect of Dnmt3a, though to varying
degrees, has been consistently observed for multiple batches
of TDG enzyme (with different purity and speciﬁc basal
activity) obtained with the same or slightly modiﬁed chro-
matography steps. Furthermore, absence of effect by Dnmt2
or a bacterial methyltransferase suggests that stimulation of
TDG activity depends on a speciﬁc interaction with Dnmt3a.
TDG represses the methylation activity of Dnmt3a
Since the Dnmt3a-TDG interaction involves the catalytic
domain of Dnmt3a, we next investigated whether TDG has
any effect on the methylation activity of Dnmt3a. The
in vitro methylation activity of Dnmt3a was measured by
scintillation-counting of the incorporation of a
3H-labeled
methyl group into a PCR fragment in reactions with or
without TDG. As shown in Figure 5, the methyltransferase
activity of Dnmt3a decreased in a dose-dependent manner.
Incubating with an equimolar amount of TDG (33 nM) resul-
ted in a reduction of Dnmt3a activity by 44% after 60 min,
compared to the reaction without TDG (Figure 5A). When
TDG was in 2-fold excess (100 nM) over Dnmt3a, this
reduced the rate of methyl transfer by 78%. TDG and other
proteins were dialyzed in buffer without salt prior to the
assay as it is known that Dnmt3a is sensitive to the NaCl con-
centration. The reactions with no TDG contained a similar
volume of the dialysis buffer, ensuring that the inhibition
was not due to any residual salt or glycerol present in the
TDG enzyme preparation.
To conﬁrm the inhibition of the Dnmt3a activity by TDG is
speciﬁc, we tested the effect of other known Dnmt3a interac-
tion partners on methylation. Dnmt3L is a general stimulatory
factor for the two Dnmt3 de novo methyltransferases and is
essential for the establishment of genomic methylation pat-
terns during germ cell development (36,37). Dnmt3L also
interacts with Dnmt3a through the catalytic domain (38).
As expected, the incubation with an equimolar amount of
Dnmt3L resulted in a 120% increase of the Dnmt3a activity
(Figure 5B). In contrast, the heterochromatin protein HP1,
which is known to interact with the PHD domain of
Dnmt3a, had no effect on the methylation activity
(Figure 5B). We also tested the effect of TDG, if any, on
two bacterial methyltransferases, M.SssI and M.HhaI. In
both cases, no signiﬁcant change in methylation activity
was caused by the addition of TDG (Figure 5C). These data
demonstrate that TDG functions as a repressor of Dnmt3a
in vitro, although the exact molecular mechanism for the
repression by TDG remains to be resolved. Presumably,
TDG, but not HP1, may have an effect on the large mamma-
lian enzyme by sterically hindering its binding to the DNA
target.
Having shown the inhibitory effect of TDG on the activity
of Dnmt3a in vitro, we then examined if TDG functions as a
negative regulator of Dnmt3a in vivo. An episomal plasmid
was transfected into 293 c18 cells with Dnmt3a and TDG
constructs in varying amounts. The recovered plasmid was
digested with the methylation-sensitive enzyme HhaI and
Southern hybridization was carried out with a probe speciﬁc
for the episomal plasmid. Three fragments of 1707, 738 and
189 bp would arise from the complete digestion when no
methylation occurred; fragments of increased sizes show
de novo methylation. As shown in Figure 5D, the fraction
of larger-size fragments decreased when Dnmt3a was co-
transfected with TDG (compare lanes 3 with 2). And when
the amount of transfected TDG construct was increased by
1- and 2-fold, the fraction of fragments of increased sizes
decreased further (Figure 5D, lanes 4, 5 and 7). This result
shows that TDG can inhibit the activity of Dnmt3a in vivo.
DISCUSSION
In the present study, we have shown that Dnmt3a can interact
with TDG both in vitro and in vivo and have mapped the
interaction domains in each protein. Both the PWWP domain
and the catalytic domain of Dnmt3a are able to mediate the
interaction with TDG at its N-terminus. The interaction
mutually affects their respective enzyme activities: Dnmt3a
stimulates the glycosylase activity of TDG while TDG
represses the methylation activity of Dnmt3a. These results
provide evidence for a possible coupling of cytosine methyla-
tion with the base-excision repair pathway.
Methylcytosines undergo spontaneous deamination at a
much higher rate than cytosines (39). The severity of the
mutagenic threat posed by methylcytosine deamination is
reﬂected in the existence of CpG islands in mammalian
genomes, which are believed to arise due to the depletion
of methylated CpG dinucleotides in the bulk of the genome
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evident in the fact that mC to T conversions account for
one-third of the mutations found in the tumor suppressor
gene p53 and other human disease genes (14,15,40). Mam-
mals, like other organisms (41), have evolved mechanisms
to counteract the mutagenic effect of methylcytosines. Of
the eight mammalian glycosylases, TDG and MBD4 are
the two enzymes that specialize in the correction of thymines
in G/T mismatches to cytosines (16,42). TDG and MBD4
show very similar catalytic speciﬁcity in the excision of
G/T mismatches in the CpG context, although their genes
appear to be unrelated. The role of MBD4 in the elimination
of deamination products in the context of a CpG dinucleotide
has been conﬁrmed in animal models (43,44).
However, the consequences of methylcytosine deami-
nation are not conﬁned to mutations. Even when the
mC!T transition can be efﬁciently repaired back to cytosine,
deamination itself still could have a profound impact on gen-
ome stability and gene expression. Both the restored cytosine
at the mismatch site and those other newly-incorporated
cytosines in the short-patch around it which are replaced by
the action of the BER pathway need to be remethylated
prior to the onset of DNA replication. If hemimethylated
CpG sites in the repaired region are not converted into fully
methylated sites, passive demethylation will occur after sub-
sequent cell divisions. Our ﬁnding that Dnmt3a interacts with
TDG, but not UDG, a uracil glycosylase which deals with the
excision repair of cytosine deamination products, lends sup-
port to the idea that there is a need for remethylation of
cytosines repaired from deaminated methylcytosines.
Our data show that TDG and Dnmt3a interact in vitro and
that overexpression of Dnmt3a causes a signiﬁcant change of
Figure 5. TDG represses the methylation activity of Dnmt3a. (A) Reduced methylation activity of Dnmt3a in the presence of TDG. The incorporation of a
tritium-labeled methyl group into substrate DNA fragments was measured in CPM at three different time points, 15, 30 and 60 min. (B) The inhibitory effect of
TDG on DNA methylation compared with other Dnmt3a-interacting proteins. Methylation reactions were carried out for 30 min with 33 nM Dnmt3a in the
absence or presence of same molar amounts of TDG, Dnmt3L or HP1. (C) Absence of inhibitory effect of TDG on the activity of M.HhaI and M.SssI
methyltransferases. The concentration used for each protein was 40 nM and the methylation reactions were carried out for 30 min. (D) The repression of in vivo
methylation activity of Dnmt3a by co-transfected TDG. A total of 0.5 mg of the assay plasmid p220.2 was co-transfected with different combinations of Dnmt3a
and TDG constructs (indicated on the top). The amount of Dnmt3a construct transfected was 0.5 mg. The amount of TDG construct ranged from 0.5 (1·) to 1.5 mg
(3·). The methylation status of the recovered assay plasmid was analyzed by digestion with the methylation-sensitive enzyme HhaI followed by Southern
hybridization. The two lower panels show the expression of Dnmt3a and TDG proteins, respectively. Results shown in (A–C) are from at least three independent
experiments. Results in (D) are representative of two independent experiments.
398 Nucleic Acids Research, 2007, Vol. 35, No. 2TDG localization (Figure 1C), suggesting it also interacts
with Dnmt3a in vivo. Although co-localization has been con-
sistently seen in several independent experiments, the overlap
is only partial: one possible explanation is that the interaction
with Dnmt3a is affected by post-translational modiﬁcation of
TDG such as sumoylation (45) or it may reﬂect the experi-
mental noise often seen when using co-transfected proteins.
It is known that mismatched G/T is recognized by either
TDG or MBD4, but transfected Dnmt3a seems to have a
stronger inherent ability to localize to heterochromatin
regions than transfected TDG. For the endogenous proteins
interacting with other components of the repair pathway in
a normal situation, the interaction domains may allow recruit-
ment to occur in the other direction, with Dnmt3a recruited to
the G/T mismatch site via interaction with either of the gly-
cosylases. In support of this view, Dnmt3a can be recruited to
the mismatch-containing oligoduplexes via association with
TDG, which recognizes G/T mismatches (Figure 2).
Supporting a Dnmt3a-TDG interaction in vivo, Dnmt3a
appears to enhance glycosylase activity in vitro, possibly by
facilitating the binding of TDG to the mismatch substrate
and/or cleavage of the mismatched thymine. In this phase,
the repressive effect of TDG on Dnmt3a could prevent a
faulty transfer of methyl groups to nearby sequences. Then
the second BER step ensues with the binding of the free aba-
sic site by the APE DNA endonuclease, which has a higher
afﬁnity than TDG to the abasic DNA. Upon dissociation of
TDG from the abasic site, Dnmt3a could remain at the repair
site through interaction with another BER component, LIG3,
the last enzyme of the short-patch BER pathway. It is note-
worthy that Dnmt3a associates with LIG3 with even higher
afﬁnity compared with TDG (Supplementary Figure 1;
P. Zhou and Y. Li, unpublished data). Cytosine remethylation
must occur after the completion of base-excision repair by
BER proteins: at this stage, TDG has left the repair site.
The repressive effect on Dnmt3a doesn’t exist anymore and
so the methyltransfer process can proceed. Factors affecting
the BER pathway or post-translational modiﬁcation of TDG
by sumoylation and acetylation (30,46) may also play a
role in the coordination of the repair and remethylation pro-
cesses.
Dnmt3b also contains the conserved PWWP and catalytic
domains shown to mediate the interaction of Dnmt3a with
TDG. Yeast two-hybrid and GST pull-down assays conﬁrmed
the physical interaction between Dnmt3b and TDG. Dnmt3b
can also stimulate the activity of TDG (data not shown). Thus
the two de novo DNA methyltransferases may both participate
in the restoration of methylation status in base-excision repair.
The remethylation of cytosines is conceivably needed in a
variety of DNA repair events involving strand re-synthesis in
a methylated genomic region. In agreement with this, Dnmt1
was recently found to be recruited to sites of DNA damages
induced by irradiation (47). However, the remethylation of
cytosines restored at G/T mismatch sites is unlikely to be
achieved by Dnmt1 since its recruitment to the repair site
depends on PCNA (47), which is absent from the polymerase
b-dependent short-patch BER pathway predominantly
operating at AP sites, which require incorporation of only a
single nucleotide (48–50). Consistent with this view, no inter-
action could be detected between Dnmt1 and TDG or LIG3
(Supplementary Figure 2).
Failure to remethylate might be an important contributor to
the genomic hypomethylation observed in various diseases
including cancer. The assessment of the biological signiﬁ-
cance of cytosine remethylation in disease as well as in
normal development requires further investigation under
physiological conditions.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR online.
ACKNOWLEDGEMENTS
The authors thank Dr G. Verdine for the pGEX-3X-hSMUG1
expression construct, Dr A. Jeltsch for pFASTBACHTc-
Dnmt1 and pET28-Dnmt2, Dr K. Yamamoto for pGEX-2T-
mHP1a, Dr K. Sugasawa for pET28-APE, Dr K. Caldecott for
pET16BXH (XRCC1), Dr T. Lindahl for pET16BHIII
(LIG3), Dr J. Christman for the method of transfection of
fluorescent tagged oligodeoxyribonucleotides and Dr J. Zhou
for discussions. Work in G.X.’s laboratory is supported by
grants from the China NSF, the Ministry of Science and
Technology of China (National Basic Research Program
2005CB522400), Shanghai Municipal Commission for
Science and Technology, and the Max Planck Society.
C.W.’s laboratory is supported by the BBSRC (BBS/B/
07403), the Northern Ireland HPSS R&D office (RRG 6.7)
and Action Cancer. Funding to pay the Open Access
publication charges for this article was provided by the
China NSF.
Conflict of interest statement. None declared.
REFERENCES
1. Li,E. (2002) Chromatin modification and epigenetic reprogramming in
mammalian development. Nature Rev. Genet., 3, 662–673.
2. Bestor,T.H. (2000) The DNA methyltransferases of mammals. Hum.
Mol. Genet., 9, 2395–2402.
3. Costello,J.F. and Vertino,P.M. (2002) Methylation matters: a new spin
on maspin. Nature Genet., 31, 123–124.
4. Bird,A.P. (1986) CpG-rich islands and the function of DNA
methylation. Nature, 321, 209–213.
5. Bird,A. (2002) DNA methylation patterns and epigenetic memory.
Genes Dev., 16, 6–21.
6. Reik,W., Kelsey,G. and Walter,J. (1999) Dissecting de novo
methylation. Nature Genet., 23, 380–382.
7. Jones,P.A. and Baylin,S.B. (2002) The fundamental role of epigenetic
events in cancer. Nature Rev. Genet., 3, 415–428.
8. Jaenisch,R. and Bird,A. (2003) Epigenetic regulation of gene
expression: how the genome integrates intrinsic and environmental
signals. Nature Genet., 33, 245–254.
9. Egger,G., Liang,G., Aparicio,A. and Jones,P.A. (2004) Epigenetics in
human disease and prospects for epigenetic therapy. Nature, 429,
457–463.
10. Duncan,B.K. and Miller,J.H. (1980) Mutagenic deamination of
cytosine residues in DNA. Nature, 287, 560–561.
11. Sved,J. and Bird,A. (1990) The expected equilibrium of the CpG
dinucleotide in vertebrate genomes under a mutation model. Proc. Natl
Acad. Sci. USA, 87, 4692–4696.
12. Cooper,D.N. and Youssoufian,H. (1988) The CpG dinucleotide and
human genetic disease. Hum. Genet., 78, 151–155.
13. Jones,P.A., Rideout,W.M.,3rd, Shen,J.C., Spruck,C.H. and Tsai,Y.C.
(1992) Methylation, mutation and cancer. Bioessays, 14, 33–36.
Nucleic Acids Research, 2007, Vol. 35, No. 2 39914. Walsh,C.P. and Xu,G.L. (2006) Cytosine methylation and DNA repair.
Curr. Top Microbiol. Immunol., 301, 283–315.
15. Pfeifer,G.P. and Holmquist,G.P. (1997) Mutagenesis in the P53 gene.
Biochim. Biophys. Acta, 1333, M1–M8.
16. Hardeland,U., Bentele,M., Lettieri,T., Steinacher,R., Jiricny,J. and
Schar,P. (2001) Thymine DNA glycosylase. Prog. Nucleic Acid Res.
Mol. Biol., 68, 235–253.
17. Krokan,H.E., Drablos,F. and Slupphaug,G. (2002) Uracil in
DNA--occurrence, consequences and repair. Oncogene, 21, 8935–8948.
18. Neddermann,P., Gallinari,P., Lettieri,T., Schmid,D., Truong,O.,
Hsuan,J.J., Wiebauer,K. and Jiricny,J. (1996) Cloning and expression
of human G/T mismatch-specific thymine-DNA glycosylase. J. Biol.
Chem., 271, 12767–12774.
19. Hendrich,B., Hardeland,U., Ng,H.H., Jiricny,J. and Bird,A. (1999) The
thymine glycosylase MBD4 can bind to the product of deamination at
methylated CpG sites. Nature, 401, 301–304.
20. Scharer,O.D. and Jiricny,J. (2001) Recent progress in the biology,
chemistry and structural biology of DNA glycosylases. Bioessays, 23,
270–281.
21. Waters,T.R., Gallinari,P., Jiricny,J. and Swann,P.F. (1999) Human
thymineDNAglycosylasebindstoapurinicsitesinDNAbutisdisplaced
by human apurinic endonuclease 1. J. Biol. Chem., 274, 67–74.
22. Kastan,M.B., Gowans,B.J. and Lieberman,M.W. (1982) Methylation of
deoxycytidine incorporated by excision-repair synthesis of DNA. Cell,
30, 509–516.
23. Ge,Y.Z., Pu,M.T., Gowher,H., Wu,H.P., Ding,J.P., Jeltsch,A. and
Xu,G.L.(2004) Chromatin targeting ofde novoDNA methyltransferases
by the PWWP domain. J. Biol. Chem., 279, 25447–25454.
24. Nguyen,T.N. and Goodrich,J.A. (2006) Protein–protein interaction
assays: eliminating false positive interactions. Nature Meth., 3,
135–139.
25. Gowher,H. and Jeltsch,A. (2001) Enzymatic properties of recombinant
Dnmt3a DNA methyltransferase from mouse: the enzyme modifies
DNA in a non-processive manner and also methylates non-CpG
[correction of non-CpA] sites. J. Mol. Biol., 309, 1201–1208.
26. Neddermann,P. and Jiricny,J. (1993) The purification of a
mismatch-specific thymine-DNA glycosylase from HeLa cells. J. Biol.
Chem., 268, 21218–21224.
27. Shimizu,Y., Iwai,S., Hanaoka,F. and Sugasawa,K. (2003) Xeroderma
pigmentosum group C protein interacts physically and functionally
with thymine DNA glycosylase. EMBO J., 22, 164–173.
28. Roth,M. and Jeltsch,A. (2000) Biotin-avidin microplate assay for the
quantitative analysis of enzymatic methylation of DNA by DNA
methyltransferases. Biol. Chem., 381, 269–272.
29. Xie,Z.H., Huang,Y.N., Chen,Z.X., Riggs,A.D., Ding,J.P., Gowher,H.,
Jeltsch,A., Sasaki,H., Hata,K. and Xu,G.L. (2006) Mutations in DNA
methyltransferase DNMT3B in ICF syndrome affect its regulation by
DNMT3L. Hum. Mol. Genet., 15, 1375–1385.
30. Tini,M., Benecke,A., Um,S.J., Torchia,J., Evans,R.M. and Chambon,P.
(2002) Association of CBP/p300 acetylase and thymine DNA
glycosylase links DNA repair and transcription. Mol. Cell, 9, 265–277.
31. Nakamura,N., Hart,D.A., Frank,C.B., Marchuk,L.L., Shrive,N.G.,
Ota,N., Taira,K., Yoshikawa,H. and Kaneda,Y. (2001) Efficient
transfer of intact oligonucleotides into the nucleus of ligament scar
fibroblasts by HVJ-cationic liposomes is correlated with effective
antisense gene inhibition. J. Biochem. (Tokyo), 129, 755–759.
32. Qiu,C., Sawada,K., Zhang,X. and Cheng,X. (2002) The PWWP domain
of mammalian DNA methyltransferase Dnmt3b defines a new family
of DNA-binding folds. Nature Struct. Biol., 9, 217–224.
33. Chen,T., Tsujimoto,N. and Li,E. (2004) The PWWP domain of Dnmt3a
and Dnmt3b is required for directing DNA methylation to the major
satellite repeats at pericentric heterochromatin. Mol. Cell. Biol., 24,
9048–9058.
34. Fuks,F., Burgers,W.A., Godin,N., Kasai,M. and Kouzarides,T. (2001)
Dnmt3a binds deacetylases and is recruited by a sequence-specific
repressor to silence transcription. EMBO J., 20, 2536–2544.
35. Gallinari,P. and Jiricny,J. (1996) A new class of uracil-DNA
glycosylases related to human thymine-DNA glycosylase. Nature, 383,
735–738.
36. Bourc’his,D. and Bestor,T.H. (2004) Meiotic catastrophe and
retrotransposon reactivation in male germ cells lacking Dnmt3L.
Nature, 431, 96–99.
37. Bourc’his,D., Xu,G.L., Lin,C.S., Bollman,B. and Bestor,T.H. (2001)
Dnmt3L and the establishment of maternal genomic imprints. Science,
294, 2536–2539.
38. Suetake,I., Shinozaki,F., Miyagawa,J., Takeshima,H. and Tajima,S.
(2004) DNMT3L stimulates the DNA methylation activity of Dnmt3a
and Dnmt3b through a direct interaction. J. Biol. Chem., 279,
27816–27823.
39. Ehrlich,M., Norris,K.F., Wang,R.Y., Kuo,K.C. and Gehrke,C.W.
(1986) DNA cytosine methylation and heat-induced deamination.
Biosci. Rep., 6, 387–393.
40. Waters,T.R. and Swann,P.F. (2000) Thymine-DNA glycosylase
and G to A transition mutations at CpG sites. Mutat. Res., 462,
137–147.
41. Bhagwat,A.S. and Lieb,M. (2002) Cooperation and competition in
mismatch repair: very short-patch repair and methyl-directed mismatch
repair in Escherichia coli. Mol. Microbiol., 44, 1421–1428.
42. Wood,R.D., Mitchell,M., Sgouros,J. and Lindahl,T. (2001) Human
DNA repair genes. Science, 291, 1284–1289.
43. Millar,C.B., Guy,J., Sansom,O.J., Selfridge,J., MacDougall,E.,
Hendrich,B., Keightley,P.D., Bishop,S.M., Clarke,A.R. and Bird,A.
(2002) Enhanced CpG mutability and tumorigenesis in
MBD4-deficient mice. Science, 297, 403–405.
44. Wong,E., Yang,K., Kuraguchi,M., Werling,U., Avdievich,E., Fan,K.,
Fazzari,M., Jin,B., Brown,A.M., Lipkin,M. et al. (2002) Mbd4
inactivation increases Cright-arrowT transition mutations and promotes
gastrointestinal tumor formation. Proc. Natl Acad. Sci. USA, 99,
14937–14942.
45. Takahashi,H., Hatakeyama,S., Saitoh,H. and Nakayama,K.I. (2005)
Noncovalent SUMO-1 binding activity of thymine DNA glycosylase
(TDG) is required for its SUMO-1 modification and colocalization
with the promyelocytic leukemia protein. J. Biol. Chem., 280,
5611–5621.
46. Hardeland,U., Steinacher,R., Jiricny,J. and Schar,P. (2002)
Modification of the human thymine-DNA glycosylase by ubiquitin-like
proteins facilitates enzymatic turnover. EMBO J., 21, 1456–1464.
47. Mortusewicz,O., Schermelleh,L., Walter,J., Cardoso,M.C. and
Leonhardt,H. (2005) Recruitment of DNA methyltransferase I to DNA
repair sites. Proc. Natl Acad. Sci. USA, 102, 8905–8909.
48. Lindahl,T. and Wood,R.D. (1999) Quality control by DNA repair.
Science, 286, 1897–1905.
49. Klungland,A. and Lindahl,T. (1997) Second pathway for completion
of human DNA base excision-repair: reconstitution with purified
proteins and requirement for DNase IV (FEN1). EMBO J., 16,
3341–3348.
50. Nilsen,H. and Krokan,H.E. (2001) Base excision repair in a network of
defence and tolerance. Carcinogenesis, 22, 987–998.
400 Nucleic Acids Research, 2007, Vol. 35, No. 2